PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
51 hedge funds and large institutions have $118M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 18 closing their positions.
Holders
51
Holders Change
-7
Holders Change %
-12.07%
% of All Funds
1.01%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
11
Increased
14
Reduced
16
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
